Title: Li X, et al. Discovery and development of Pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer. Eur J Pharm Sci. 2017 Jan 21. pii: S0928-0987(17)30043-X.
1397922-61-0
1269662-73-8
915942-22-2
201410-66-4 | (+)-Talarozole | AA01EOAY | MFCD31619294
1361951-15-6 | TP-3654 | AA01EOGQ | MFCD28502206
313526-24-8 | IBR2 | AA01EOM1 | MFCD00991660
958759-75-6 | 9α-hydroxy-11-methylene-15-oxo-prosta-5Z,13E-dien-1-oicacid | AA01EOQN
63199-70-2 | (αS)-rel-[(1R)-1-(methylamino)propyl]-benzenemethanol,monohydrochloride | AA01EP12
1431520-52-3 | α-cyclopropyl-N-methyl-1,3-benzodioxole-5-ethanamine,monohydrochloride | AA01EPB5
1047670-51-8 | [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl](4-methoxyphenyl)-methanone | AA01EPI8
848035-21-2 | 4-methoxy-3,5-bis[[2-methoxy-5-[2-(methylamino)ethyl]phenyl]methyl]-N-methyl-benzeneethanamine,trihydrochloride | AA01EPO4
1449768-48-2 | (2S)-2-[[3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-pyrrolidinecarboximidamide,monohydrochloride | AA01EPUI
1620233-72-8 | 3-amino-1-[5,6-dihydro-5,6-d2-3-(trifluoromethyl)-1,2,4-triazolo[4,3-α]pyrazin-7(8H)-yl-5,6-d2]-4-(2,4,5-trifluorophenyl)-1-butanone,monohydrochloride | AA01EQ42
